Clinical Study of 68Ga Labeled HER2 Affibody Analogues

Clinical trial NCT05411432 · UNKNOWN

Trial details

NCT number: NCT05411432
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

HER2-positive Breast Cancer and Gastric Cancer

Start date: 2022-06-01
Primary completion: 2023-06-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.